InvestorsHub Logo
Followers 67
Posts 16221
Boards Moderated 2
Alias Born 02/14/2011

Re: None

Friday, 02/01/2013 1:08:19 PM

Friday, February 01, 2013 1:08:19 PM

Post# of 110
12:20 PM Medivation (MDVN +3.4%) moves up today after its Japanese alliance partner Astellas Pharma reported in its financial results last night that it expects Xtandi sales to exceed year-end net sales targets ending on March 31. MDVN is due to report at the end of February. Separately, Jefferies raises its price target on the shares from $62 to $64